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Abstract
Purpose—To examine the effect of time spent viewing images and level of confidence on a
screening mammography test set on interpretive performance.
Materials and Methods—Radiologists from six mammography registries participated in the
study and were randomized to interpret one of four test sets and complete 12 survey questions.
Each test set had 109 cases of digitized four-view screening film-screen mammograms with prior
comparison screening views. Viewing time for each case was defined as the cumulative time spent
viewing all mammographic images before recording which visible feature, if any, was the “most
significant finding”. Log-linear regression fit via GEE was used to test the effect of viewing time
and level of confidence in the interpretation on test set sensitivity and false-positive rate.
Results—119 radiologists completed a test set and contributed data on 11,484 interpretations.
Radiologists spent more time viewing cases that had significant findings or for which they had less
confidence in interpretation. Each additional minute of viewing time increased the probability of a
true positive interpretation among cancer cases by 1.12 (95% CI: 1.06, 1.19, p<0.001), regardless
of confidence in the assessment. Among radiologists who were ‘very confident’ in their
assessment, each additional minute of viewing time increased the adjusted risk of a false positive
interpretation among non-cancer cases by 1.42 (95% CI 1.21, 1.68), and this viewing-time effect
diminished with decreasing confidence.
Conclusions—Longer interpretation times and higher levels of confidence in the interpretation
are both associated with higher sensitivity and false positive rates in mammography screening.
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Little is known about how time spent examining different types of mammographic images
affects interpretive accuracy outside of comparisons between digital and screen film
mammography or mammography with and without use of computer-aided detection (1-8). In
one study, Saunders, et al (1, 2) found that incorrect detection decisions for both cancer and
non-cancer cases, and incorrect decisions about needed work-up were both associated with
longer interpretation time for screening mammography. In another study, Nodine, et al (3)
found that a high level of confidence was associated with both shorter fixation dwell times
(time spent looking at a specific area on a film and time spent initially scanning the image,
and that one second of fixation dwell time (coupled with a high level of confidence) versus
time spent initially scanning the image were associated with detection of true positive
lesions for experienced radiologists. They also found that prolonging the search beyond the
global recognition time yielded few new lesions and increased the risk of error. Kundel, et al
(4) found that expert radiologists fixated on a cancer in 1.13 seconds and that proficient
radiologists appear to use a fast holistic scanning mode rather than a search-to-find-mode.
Understanding how time spent interpreting mammography affects performance could assist
radiologists in avoiding viewing behaviors unlikely to improve accuracy.
Weaknesses of all the above studies include that very few experienced radiologists were
included (between 1 and 6), so adjustment for radiologists characteristics known to affect
performance were not addressed, and none of the studies examined the particular features
being examined in either normal or abnormal images. Understanding the relationships
among time spent, complexity of the images and interpretive accuracy, while adjusting for
possible confounders, could aid in identifying which types of mammographic findings might
benefit from a second opinion. In addition, conducting an in-depth assessment of initial
radiologists’ time spent and confidence in their assessment could potentially improve
interpretive performance and be more effective than double reading all screening
mammograms. We conducted a study with radiologists across the U.S. to examine these
issues and to specifically test the hypothesis that more versus less time spent interpreting




This study was conducted with six mammography registries (Carolina Mammography
Registry, New Hampshire Mammography Network, New Mexico Mammography Project,
Vermont Breast Cancer Surveillance System, and Group Health Cooperative in western
Washington) associated with the National Cancer Institute funded Breast Cancer
Surveillance Consortium (BCSC; http://breastscreening.cancer.gov). Data collected as part
of this study were pooled at the BCSC Statistical Coordinating Center (SCC) in Seattle, WA
for analysis. Each registry and the SCC received IRB approval for either active or passive
consenting processes or a waiver of consent to enroll participants, link data, and perform
analytic studies. All procedures are Health Insurance Portability and Accountability Act
compliant and all registries and the SCC have received a Federal Certificate of
Confidentiality (9) and other protection for the identities of women, physicians, and
facilities that are subjects of this research. In addition, each registry and the SCC received
IRB approval for all test set study activities.
Radiologists who interpreted mammograms at a facility contributing to any of the registries
between January 2005 and December 2006 were invited to participate. We also invited 103
non-BCSC radiologists from Oregon; Puget Sound, WA; North Carolina, San Francisco, and
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New Mexico. A total of 469 radiologists were invited to participate, and 148 (31.6%)
consented. Among these, 119 (80.4%) completed all study activities.
Test Set Design and Development
We selected test set cases based on cancer prevalence and expert rated difficulty identifying
breast cancer to create four screening mammography test sets with 109 cases in each set.
This approach was used because the goal of the larger study was to assess how cancer
prevalence and type of finding (subtle, intermediate and obvious) as interpreted on a test set
would correlate with actual clinical practice. The results of the larger study will be reported
elsewhere.
All cases were randomly selected from screening examinations performed on women aged
40 to 69 between 2000 and 2003 from the six participating BCSC mammography registries.
Women who had a mastectomy and those with a prior history of breast cancer were
excluded. Participating registries contributed between 42 and 84 screening mammography
examinations, all of which had a mammogram within the prior 11-30 months. Of these
approximately 26-48% were selected from each site for use in a test set. Examinations with
stray marks or other quality issues on the films were excluded. Each screening examination
selected consisted of craniocaudal (CC) and mediolateral oblique (MLO) views of each
breast (4 views per woman for each of the screening and comparison examinations). For
cancer cases, we selected images from exams for which cancer was diagnosed within 12
months following the mammogram. Non-cancer cases came from women who were cancer
after at least two years following the mammogram. Final cases in the test sets came from 36
women known to have been diagnosed with cancer within one year of imaging, and from 94
women who remained cancer-free for two years following the imaging. Cases from these
women were used more than once to configure the test sets appropriately.
The case sampling design was stratified based on clinical interpretations as true positive,
true negative, false positive and false negative and were reviewed by an expert panel of
radiologists (n=3), which was blinded to the original mammography interpretation and
cancer status. The experts also categorized significant findings as mass, calcification,
asymmetric density or architectural distortion; and as obvious, intermediate or subtle.
Obvious findings were defined as those the expert panel agreed that 100% of community
radiologists should identify. Intermediate finding were defined as those the expert panel
agreed 25-99% of community radiologists would identify. Subtle findings were defined as
those the expert panel indicated <25% of community radiologists would identify. The
experts reached consensus on any interpretation for which an initial disagreement occurred.
We randomly selected 60 TP examinations and 16 FN examinations, so the experts could
identify 14 obvious cancers, 15 intermediate cancers, and 9 subtle cancers for inclusion in a
test sets. To include FP examinations, we selected examinations with BI-RADS assessment
categories 0, 4 or 5 that were not associated with breast cancer within 24 months of
mammography. The remaining examinations were TN examinations of both breasts. The
composition of Test Sets 1 and 2 included: 47% obvious, 40% intermediate, 13% subtle, and
the composition of Test Sets 3 and 4 included 20% obvious, 50% intermediate, 30% subtle.
Test sets 1 and 2 each contained 15 cancer and 94 non-cancer cases. Test sets 3 and 4 both
contained 30 cancer and 79 non-cancer cases. After cases were selected, the films were
digitized by experts at the American College of Radiology using a Vidar Diagnostic Pro (10)
and loaded into specially designed viewing software that allowed us to collect timing and
location information associated with interpretations.
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We randomized consenting radiologists to one of the four test sets. The test sets were self-
administered using custom designed software distributed on a DVD. Participants were block
randomized within strata defined by registry/site and whether a radiologist had reviewed at
least 30 cancers in the BCSC database to ensure an equal number of radiologists with
accurate measures of clinical sensitivity of mammography were reading each test set. This
criterion was not used for non-BCSC participants.
Each site sent consenting radiologists the DVD along with an instruction sheet informing
them of their assigned test. Radiologists used either a home or work computer or laptop
provided by the study with a large size screen and high-resolution graphics (≥1280×1024,
≥3GHz, 1GB of RAM, and a video card with 128MB of memory capable of displaying full
32-bit color at the listed resolutions and a DVD reader) to show 2 images at the same time.
The monitor specifications were provided to radiologists if they chose to use their home or
work computers. The software developed for the study allowed radiologists to: 1) choose
whether the images were displayed with right breast facing right or left and left breast facing
left or right; 2) rapidly toggle (≤1 second) between the display of paired images so that
visual memory is retained from one displayed pair to the next; 3) magnify a portion of the
displayed image; and 4) point and click on any important abnormality to record the
coordinates of findings to enable capture of whether a radiologist has identified and located
the lesion of highest suspicion for cancer.
Participating radiologists were instructed to interpret test sets as they would in clinical
practice. Radiologists were informed that the overall cancer rate on test sets was higher than
that found in a screened population (11), but they were not informed of the specific
prevalence of positive examinations or cancers in the test sets. We used this approach so that
all radiologists would interpret test sets with similar knowledge of the underlying prevalence
of disease instead of assuming the prevalence to be similar to their own clinical experience.
Measures
Participant Characteristics—Prior to evaluating test set digitized mammography films,
the software prompted each participant to answer 12 demographic and clinical practice
survey questions, including receipt of fellowship training, specialization, number of years
spent interpreting mammograms, and the number of mammograms interpreted per week. In
addition, we made use of the test set assignment as a radiologist-level characteristic, as it
captured the case mixture and difficulty of films.
Outcome Measures—Our analyses focus on mammographic test set performance. As
participants viewed individual cases in the test set, they were prompted to identify the most
significant visible breast abnormality, and to decide whether or not the patient should be
recalled for additional work-up. The decision to recall constituted a positive test result for
our analyses. Recall decisions on mammography exams were modeled conditionally based
on the patients’ true cancer status, and other relevant covariates described in the data
analysis section, to estimate effect of the time spent viewing films on sensitivity and false-
positive probability.
Time Measurement and Image Viewing Process—The test-set software randomly
presented the images in a similar manner to digital mammogram interpretation using a single
monitor. Each case was presented in a sequence including MLO and CC views of both
breasts simultaneously, followed by MLO and CC views of each breast paired with the
analogous image from the previous exam to assess whether changes from the prior
mammogram were apparent. Figure 1 illustrates an example case with image presentation
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shown from the Test Set software. Images could be magnified as needed. The software
recorded the length of time, measured in seconds, the user spent viewing each individual
film, which was defined as the cumulative time spent viewing all mammographic images
and identifying which, if any, visible feature was the most significant finding by a mouse
click.
Radiologists were encouraged by a pop-up message within the program to examine all
available images, including both current and comparison views, before indicating their
decisions about any of the individual images to ensure viewing consistency during the study.
Because the assessment software did not have a pause feature, any time spent away from the
computer during the completion of the test set was added to the cumulative time associated
with the most recently started exam. To minimize the impact on our analyses, we assessed
viewing time in a controlled setting with seven radiologists viewing 320 cases where
interrupted viewing time was not possible and found that >98% of interpreters completed
viewing all study images for each case within five minutes, which our expert radiologists
concurred with. Examinations for which viewing time exceeded 5 minutes (n=1,443) were
excluded from our analyses since they likely represented a mix of uninterrupted and
interrupted viewing durations.
Other Exam-Level Characteristics—Breast density was categorized as almost entirely
fat, <25%; scattered fibroglandular densities, 25–50%; heterogeneously dense, 51–75%; or
extremely dense, >75% (12). Users reported confidence in their assessment on each exam as
either not at all confident, not very confident, neutral, confident, or very confident. For our
analyses, we combined the responses for ‘Not at all confident’ and ‘Not very confident’ to
form a ‘Not Confident’ category.
We recorded the expert-assessed lesion type for each case as one of either mass;
calcification, asymmetry, or architectural distortion. This variable was classified as missing
when the expert consensus indicated there was no significant finding.
Data Analysis
All but one radiologist, who reviewed only 104 cases, reviewed all 109, resulting in 12,966
interpretations. Of these, 1,443 (11%) observations were excluded because their duration
exceeded five minutes, and an additional 39 (0.3%) were excluded due to errors in time
recording caused by computer problems. In all, 11,484 (89%) interpretations were suitable
for analyses.
We calculated frequency distributions for responses to the 12 demographic questions by test
set assignment. To address the primary scientific question of the effect of viewing time on
radiologist’s test set performance, we modeled the relative risk of a positive assessment
(recall) using log-linear regression. To account for the correlation within both radiologists
and exams, we implemented an extension of GEE developed specifically for analysis of
non-nested multilevel data (13, 14).
We regressed a binary indicator of recall on viewing time and examination-level, patient-
level, and radiologist-level covariates using a log-link function to estimate relative risks. Our
models made a Poisson variance assumption, which yields valid variance estimates for
relative risk in analyses of common binary outcomes (15), and applied the robust Huber-
White sandwich variance estimator. We separately modeled sensitivity and false-positive
rates. For both cancer and non-cancer exams, we modeled the probability of recall as a
function of viewing time, with and without adjustment for: radiologist’s confidence on the
exam; the radiologist’s assessment of breast density; the expert-identified lesion type; and
the radiologist’s fellowship category, specialization, years interpreting mammograms,
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number of mammograms read per week, and random test set assignment. We expressed
viewing time in the model using a single linear term, and expressed each categorical
covariate with an appropriate group of indicator variables.
We hypothesized that the effect of viewing time on the probability of recall may differ
according to the radiologist’s confidence interpreting the exam and assessed whether
confidence modified the effect of viewing time on the risk of recall by including interaction
terms between viewing time and each indicator associated with confidence. In analyses
where interactions were statistically significant, we calculated confidence-level specific
estimates of the relative risk of recall associated with a one-minute increase in viewing time.
Where the interaction was not significant, we omitted it from the regression models, and
estimated a time effect across levels of confidence. All analyses were conducted using the R
statistical software, version 2.10.0 (16, 17).
RESULTS
Seventy-six of 119 participating radiologists (64%) reported interpreting mammograms for
more than 10 years, and 86 (72%) reported reading at least 50 mammograms per week
(Table 1). Fifteen radiologists (13%) reported completion or plans to complete a fellowship
in breast or women’s imaging.
Figure 2 presents the mean and inter-quartile range (IQR) for viewing time for the 2,291
exams of images belonging to 36 women known to have been diagnosed with cancer within
one year of imaging, and for 9,193 exams of images from 94 women who remained cancer-
free for two years following the imaging. Results are shown by cancer status and the
confidence level each radiologist selected following the exam, with horizontal reference
lines indicating the 25th, 50th, and 75th percentiles of the viewing time distribution among
cancer and non-cancer exams. Median times associated with exams resulting in a positive
assessment, shown with a solid vertical bar, were higher than negative exams, shown with a
dotted bar, for cancers and non-cancers and across all levels of confidence. Among both
cancer and non-cancer exams, median viewing times were shorter for exams on which
radiologists endorsed greater confidence, and longer for exams on which readers were less
confident.
Table 2 illustrates the median viewing times and IQRs for all examinations in groups
defined by expert-identified finding type and participant-rated BI-RADS (12) breast density.
Median viewing times for exams containing any expert findings were longer than for those
with none, with the exception of those containing a mass. Fatty and extremely dense breasts
have similar properties in terms of time spent viewing. Both have shorter viewing times than
scattered and heterogeneously dense for cases with no findings and most cases with
findings. Among exams with expert findings, those containing masses corresponded to the
shortest median viewing times, and calcifications to the longest, except in cases where
breasts were almost entirely fatty for which asymmetries had the longest median viewing
time.
Among cases with cancer, each additional minute of viewing time increased the adjusted
probability of a true positive assessment by a factor of 1.12 (95% CI: 1.06, 1.19), p<0.001
(Table 3). This effect did not significantly differ by radiologist confidence in assessment
before (p=0.88) or after (p=0.73) adjustment for expert-identified lesion type, reader-rated
breast density, fellowship category, specialization, years interpreting mammograms,
mammograms read per week, and random test set assignment. Confidence in the assessment
was significantly associated with a true positive assessment both before (p=0.003) and after
(p<0.001) covariate adjustment. Radiologists who reported being very confident in their
Carney et al. Page 6













assessment were 1.32 (95% CI: 1.16, 1.50) times more likely to have correctly recalled the
patient than those reporting neutral confidence.
The relative risk of false positive assessments, estimated from examinations of women who
remained free of breast cancer for one year after imaging, illustrated that the relationship
between viewing time and false positive probability differed significantly by radiologist
confidence (Table 3), both before (p=0.016) and after (p=0.039) adjustment for the factors
mentioned above. The unadjusted association between confidence and the risk of a false
positive was statistically significant (p<0.001). False positive exams were about half
(RR=0.55, 95% CI: 0.36, 0.86) as likely among very confident examiners as among those
reporting neutral confidence. Those who reported being not very confident or not at all
confident were 1.41 (95%CI: 1.17, 1.69) times more likely to recall the patient.
The effect of viewing time on the probability of a false positive assessment was significant
across all confidence levels, both before and after covariate adjustment. For those who were
‘Very confident’ in their assessment, each additional minute of viewing time increased the
adjusted risk of a false positive by a factor of 1.42 (95% CI: 1.21, 1.68). Relative risk
estimates diminished monotonically according to falling confidence. For those reporting
‘Confident’ assessments, the risk increased by a factor of 1.40 (95% CI: 1.29, 1.52), for
‘Neutral’ assessments by a factor of 1.38 (95% CI: 1.29, 1.48), and for those who were
either ‘Not very confident’ or ‘Not at all confident’ in their assessment, by a factor of 1.20
(95% CI: 1.10, 1.31).
DISCUSSION
This study is the largest conducted to-date with 119 radiologists and 11,484 interpretations
analyzed to examine the relationships among viewing time, type of finding, confidence and
accuracy when interpreting mammography. We found that radiologists spent more time
viewing mammographic findings that they ultimately recalled rather than those that those
they did not recall and that higher confidence was usually associated with shorter viewing
times. Among cancer cases, increasing viewing time increased the probability of a true
positive interpretation. We also found that among non-cancer exams for which radiologists
felt ‘very confident’ in their assessment, each additional minute of viewing time increased
the adjusted risk of a false positive interpretation by 42% and that this effect diminished
according to decreasing confidence.
These findings illustrate the complex relationship between view time and confidence. While
increased viewing time resulted in a small increase in sensitivity, it decreased specificity to a
much larger extent. Thus, radiologists may not benefit from spending more time on an
interpretation they are not confident in, but may benefit from asking a colleague for a second
opinion, which may assist less experienced radiologists in gaining knowledge about and
confidence in their interpretations. Addressing confidence in an educational setting may be
challenging as most continuing medical education is designed to address knowledge deficits
that may or may not exist, and changes in knowledge often do not translate to improvements
in skill (18). Interestingly, our findings do not appear to be related to fellowship training,
years of experience, or specialization in breast imaging. One might hypothesize that such
educational experiences should shorten the time needed to interpret a mammogram, but little
exists in the literature on this important topic. Double reading is used extensively outside the
U.S. (19, 20), which appears to reduce recall rates without affecting cancer detection.
Double reading is not done routinely in the U.S., principally because radiologists are not
reimbursed for it; though, double reading on cases that take a long time to interpret might
improve specificity.
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Our study differs from those of Kundel, Nodine et al and others (2, 3, 21-23), who have
studied eye position and fixation dwell times using a computer eye-head tracking system.
While we also used an interactive computer system that included time assessments, we did
not specifically measure eye movements. Like these investigators, we found that longer time
spent on the interpretation yielded lower specificity though the 2002 study only included
nine radiologists and six of them were trainees (2). Another difference is that these
investigators did not include specific measures of confidence as we did in our study.
In another study, Castella et al (24) studied the influence of signal variability on human and
model observers for detection tasks using simulated masses superimposed on both real
patient mammographic backgrounds and synthesized mammographic backgrounds with
clustered lumpy backgrounds. They found that human observers’ performance did not vary
when benign masses were superimposed on real images or on the synthesized background.
Uncertainty and variability in signal shape did not significantly affect human performance
though variability in signal size did. Our findings differ in that we found level of confidence,
a concept reflective of uncertaintly, in the interpretation influenced interpretive accuracy.
Our study shows that interpretation using a test set methodology involves variation in time
spent, level of confidence and accuracy. More time spent and lower confidence appears to
result in much higher recall rates with many more false positive exams and only a small
increase in sensitivity. Interventions that recognize this issue could reduce false positive
cases without altering sensitivity. Options such as selective requests for a second opinion
should be tested. These might involve academic detailing (university-based educational
outreach involving face-to-face education by trained health care professional) (25-27),
which has shown improved performance in physicians’ use of pharmacologic agents.
The strengths of our study include the large number of participating radiologists from
around the U.S and the large number of images our analysis was based upon. Another
strength is that we designed the test set software so that it was similar to interpreting digital
mammography, which is now being used in greater than 70% of mammography facilities
across the U.S., so it is similar to clinical practice (28). Limitations include that physicians
could not be kept blind to the fact that their interpretations of the test set were being studied,
so their interpretations could have been influenced by the Hawthorne effect (knowledge that
they were participating in a study could have affected their interpretive behavior) (29). In
addition, though we used the American College of Radiology Guidelines for computer
monitor display capabilities for diagnostic radiology (30), image quality in this field is
advancing rapidly and monitors did improve over the study period. Similarly, radiologists
use of two monitors for interpretive viewing increased over this time period, which may
have resulted in variability of study findings. We also used a control setting with seven
radiologists to identify a cut point for maximum viewing time and found that >98% viewed
the cases within this time period. Only two percent took longer than five minutes in our
controlled setting. Though this time might be longer when radiologists interpreted in their
home or work settings, we do not think it will have affected our findings to any significant
degree.
In conclusion, longer interpretation times and higher levels of confidence appear to be
independently associated with a small increase in sensitivity to detect cancers in screening
mammography; however, longer interpretation times also appear to be associated with a
much greater risk of false positives, and this association increases in magnitude with higher
levels of confidence.
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Example Case of Image Presentation in the Test Set Software
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Median and interquartile range of viewing times by true cancer status and radiologist
confidence.
Confidence categories: VC= very confident, C= confident, N = neutral, NC = not confident.
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Table 1
Radiologist Characteristics at Baseline by Randomized Test Set Assignment
Test Set*
1 (n=30) 2 (n=34) 3 (n=28) 4 (n=27)
Number of mammography examinations
read/week n (%) n (%) n (%) n (%)
 Up to 10 2 (7%) 2 (6%) 2 (7%) 2 (7%)
 11-49 8 (27%) 10 (29%) 4 (14%) 3 (11%)
 50-99 7 (23%) 10 (29%) 10 (36%) 9 (33%)
 100-199 7 (23%) 8 (24%) 9 (32%) 7 (26%)
 200 or more 6 (20%) 4 (12%) 3 (11%) 6 (22%)
Category 1 CME hours in mammography
received in the past three years (not
including this program)
 None 1 (3%) 0 (0%) 3 (11%) 0 (0%)
 1-10 2 (7%) 3 (9%) 2 (7%) 0 (0%)
 11-15 5 (17%) 6 (18%) 6 (21%) 4 (15%)
 16-30 10 (33%) 14 (41%) 8 (29%) 13 (48%)
 31 or more 12 (40%) 11 (32%) 9 (32%) 10 (37%)
Specialization in radiology
 Generalist (no specialization) 10 (33%) 6 (18%) 5 (18%) 5 (19%)
 Primarily generalist (some specialization) 9 (30%) 15 (44%) 12 (43%) 12 (44%)
 Primarily Specialist (some general work) 9 (30%) 11 (32%) 9 (32%) 7 (26%)
 Breast Specialist (no general work) 2 (7%) 2 (6%) 2 (7%) 3 (11%)
Current main practice type
 Community practice radiology group 16 (53%) 19 (56%) 15 (54%) 16 (59%)
 Academic radiology group 5 (17%) 4 (12%) 4 (14%) 4 (15%)
 Radiologist in a multispecialty group 7 (23%) 5 (15%) 6 (21%) 3 (11%)
 Solo radiology practice 0 (0%) 1 (3%) 2 (7%) 3 (11%)
 Locum tenens 2 (7%) 4 (12%) 1 (4%) 0 (0%)
 Other 0 (0%) 1 (3%) 0 (0%) 1 (4%)
Completed post-residency fellowship
 Yes, in Breast or Women’s Imaging 3 (10%) 2 (6%) 4 (14%) 6 (22%)
 Yes, other 14 (47%) 16 (47%) 13 (46%) 8 (30%)
 No 13 (43%) 16 (47%) 11 (39%) 13 (48%)
Number of days per week working in
breast imaging in past year
 1 day or less 9 (30%) 12 (35%) 8 (29%) 5 (19%)
 2 days 5 (17%) 5 (15%) 6 (21%) 8 (30%)
 3 days 7 (23%) 7 (21%) 9 (32%) 5 (19%)
 4 days 3 (10%) 6 (18%) 2 (7%) 4 (15%)
 5 days 6 (20%) 4 (12%) 3 (11%) 5 (19%)
Years interpreting mammograms
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Test Set*
1 (n=30) 2 (n=34) 3 (n=28) 4 (n=27)
 1-5 years 9 (30%) 7 (21%) 6 (21%) 3 (11%)
 6-10 years 2 (7%) 6 (18%) 5 (18%) 5 (19%)
 11-20 years 13 (43%) 14 (41%) 13 (46%) 11 (41%)
 21-30 years 3 (10%) 4 (12%) 4 (14%) 6 (22%)
 31 years or more 3 (10%) 3 (9%) 0 (0%) 2 (7%)
Estimated number of mammograms per
year interpreted over the last 5 years
 Don’t know 10 (33%) 6 (18%) 5 (18%) 8 (30%)
 0 to 1000 2 (7%) 8 (24%) 2 (7%) 3 (11%)
 1001 to 2000 7 (23%) 10 (29%) 5 (18%) 4 (15%)
 2001 to 3000 5 (17%) 2 (6%) 11 (39%) 4 (15%)
 More than 3000 6 (20%) 8 (24%) 5 (18%) 8 (30%)
Self-rated ability to perceive & determine
importance of mammographic findings
 Not sure 2 (7%) 0 (0%) 0 (0%) 1 (4%)
 Below Average 0 (0%) 0 (0%) 1 (4%) 1 (4%)
 Average 15 (50%) 20 (59%) 12 (43%) 6 (22%)
 Above Average 9 (30%) 12 (35%) 15 (54%) 14 (52%)
 Expert 4 (13%) 2 (6%) 0 (0%) 15 (19%)
 Currently interprets digital screening exams 3 (10%) 7 (21%) 6 (21%) 7 (26%)
Where did you review this DVD application
 Home computer 11 (37%) 14 (41%) 13 (46%) 12 (44%)
 Office computer 3 (10%) 5 (15%) 1 (4%) 4 (15%)
 Radiology reading room workstation 2 (7%) 3 (9%) 0 (0%) 1 (4%)
 Study Laptop 12 (40%) 12 (35%) 13 (46%) 9 (33%)
 Other 2 (7%) 0 (0%) 1 (4%) 1 (4%)
*
Participants were block randomized within strata defined by registry/site and whether or not a radiologist had reviewed at least 30 cancers in the
BCSC database to balance the number of radiologists with accurate measures of clinical sensitivity of mammography across test sets. Non-BCSC
radiologists were considered to be in the group of radiologists who did not review at least 30 cancers.
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Table 2
Median Viewing Time and Inter-quartile Range in Seconds Overall and by Radiologist-assessed Breast




Type Mass Calcification Asymmetry
Architectural
Distortion












 Almost Entirely Fat
(<25%)
80 (53, 123)
n = 1,615 (23%)
98 (63, 142)
n = 326 (7%)
84 (58, 112)
n = 78 (9%)
104 (80, 128)
n = 49 (4%)
122 (70, 163)
n = 96 (7%)
89 (58, 148)





n = 2,569 (37%)
105 (71, 152)
n = 1,856 (41%)
94 (64, 134)
n = 503 (56%)
111 (79, 162)
n = 485 (41%)
108 (74, 150)
n = 517 (36%)
101 (71, 161)





n = 2,127 (30%)
104 (72, 150)
n = 1,638 (36%)
93 (66, 133)
n = 266 (30%)
113 (77, 164)
n = 461 (39%)
107 (72, 151)
n = 465 (33%)
102 (73, 146)




n = 673 (10%)
102 (69, 154)
n = 679 (15%)
82 (63, 103)
n = 53 (6%)
110 (74, 177)
n = 175 (15%)
104 (71, 147)
n = 351 (25%)
98 (61, 149)
n = 100 (10%)
FG = fibroglandular Percents shown are column percents
*
One of the 6,985 lesion-free exams was not assessed for density
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Table 3
Relative risk of recall among cancer films and non-cancer films
Unadjusted RR p Adjusted RR† p
Among Cancer Films:
 Viewing Time, 1 minute increase 1.10 (1.04 ,1.17) 0.002 1.12 (1.06 ,1.19) <0.001
 Radiologist confidence on current exam 0.003 <0.001
  Very Confident 1.30 (1.11 ,1.53) 1.32 (1.16 ,1.50)
  Confident 1.15 (1.04 ,1.27) 1.13 (1.04 ,1.23)
  Neutral 1 (referent) 1 (referent)
  Not Confident‡ 0.93 (0.75 ,1.17) 0.94 (0.77 ,1.16)
Among Non-Cancer Films:
 Viewing Time, 1 minute increase 1.42 (1.32 ,1.53) <0.001 –
 Radiologist confidence on current exam <0.001
  Very Confident 0.55 (0.36 ,0.86) –
  Confident 0.68 (0.56 ,0.82) –
  Neutral 1 (referent) –
  Not Confident 1.41 (1.17 ,1.69) –
 Confidence-Specific Viewtime Effects
  Viewing Time, 1 minute increase 0.016* 0.039*
   on Very Confident exams 1.50 (1.30 ,1.74) 1.42 (1.21 ,1.68)
   on Confident exams 1.41 (1.29 ,1.54) 1.40 (1.29 ,1.52)
   on Neutral exams 1.38 (1.30 ,1.48) 1.38 (1.29 ,1.48)
   on Not Confident exams 1.19 (1.08 ,1.31) 1.20 (1.09 ,1.31)
†
Models are adjusted for expert-identified lesion type, reader-rated breast density, fellowship category, specialization, years interpreting
mammograms, mammograms read per week, and random test set assignment. No significant interaction was found between viewing time and
confidence among cancer films (p=0.73). Adjusted model for non-cancer films contains an interaction (p=0.039) between viewing time and exam-
level confidence, and so confidence-specific viewtime estimates are presented here.
‡
Radiologists reporting ‘Not very confident’ or ‘Not at all confident’ are combined in the ‘Not confident’ group
*
P value from test for interaction between confidence and viewing time
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